What is a stock summary page? Click here for an overview.
Business Description
Homology Medicines Inc
NAICS : 325412
SIC : 2834
ISIN : US4380831077
Compare
Compare
Traded in other countries / regions
FIXX.USA35H.Germany0T6G.UK Index Membership
Russell 2000 IPO Date
2018-03-28Description
Homology Medicines Inc is a United States-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -26.32 | |||||
| 12-1 Month Momentum % | -5.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -8344.12 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-EBITDA | -0.02 | |||||
| EV-to-Forward-Revenue | 0.94 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:FIXX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Homology Medicines Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.156 | ||
| EPS (TTM) ($) | -35.1 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -0.86 | ||
| 3-Year Sortino Ratio | -0.99 | ||
| Volatility % | 98.36 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 1.958387 | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | -5.26 | ||
| 52-Week Range ($) | 0.9 - 26.639999 | ||
| Shares Outstanding (Mil) | 3.23 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Homology Medicines Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Homology Medicines Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Homology Medicines Inc Frequently Asked Questions
What is Homology Medicines Inc(FIXX)'s stock price today?
The current price of FIXX is $0.93. The 52 week high of FIXX is $26.64 and 52 week low is $0.90.
When is next earnings date of Homology Medicines Inc(FIXX)?
The next earnings date of Homology Medicines Inc(FIXX) is 2025-08-14 Est..
Does Homology Medicines Inc(FIXX) pay dividends? If so, how much?
Homology Medicines Inc(FIXX) does not pay dividend.
Guru Commentaries on NAS:FIXX
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers